| Literature DB >> 34045484 |
Ehsan Valiey1, Mohammad G Dekamin2, Zahra Alirezvani1.
Abstract
This study introduces a practical approach to fabricate a novel hybrid acidic catalyst, namely sulfamic acid pyromellitic diamide-functionalized MCM-41 (MCM-41-APS-PMDA-NHSO3H). Various techniques such as FTIR, TGA, XRD, BET, FESEM, and EDX were used to confirm its structural characteristics. The efficiency of the new MCM-41-APS-PMDA-NHSO3H organosilica nanomaterials, as a heterogenous nanocatalyst, was examined in the synthesis of biologically active 3,4-dihydropyrimidin-2-(1H)-one derivatives under solvent-free conditions. It was found that the nanoporous MCM-41-APS-PMDA-NHSO3H, demonstrating acidic nature and high surface area, can activate all the Biginelli reaction components to afford desired 3,4-dihydropyrimidin-2-(1H)-ones under solvent-free conditions in short reaction time. Furthermore, easy and quick isolation of the new introduced hybrid organosilica from the reaction mixture as well as its reusability with negligible loss of activity in at least five consecutive runs are another advantages of this green protocol.Entities:
Year: 2021 PMID: 34045484 PMCID: PMC8159994 DOI: 10.1038/s41598-021-89572-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Scheme 1Schematic preparation of MCM-41-APS-PMDA-NHSO3H (1) for the three-component condensation of ethyl acetoacetate (2), aldehydes (3), urea (4) to afford 3,4-dihydropyrimidin-2-(1H)-one derivatives (5).
Figure 1FTIR spectra of the MCM-41 (a), MCM-41-APS (b), MCM-41-APS-PMDA (c) and MCM-41-APS-PMDA-NHSO3H (d) (1).
Figure 2FESEM images of the MCM-41 (a–c) and the MCM-41-APS-PMDA-NHSO3H (1, d–f) materials.
Figure 3TGA analysis of the MCM-41-APS-PMDA-NHSO3H materials (1).
Figure 4EDX spectra of the MCM-41-APS-PMDA-NHSO3H materials (1).
Figure 5Low angle (a) and wide angle (b) XRD patterns of the hybrid MCM-41-APS-PMDA-NHSO3H nanocatalyst (1).
Figure 6Adsorption/desorption isotherm of the MCM-41-APS-PMDA-NHSO3H nanocatalyst (1).
Optimization of conditions in the model reaction of ethyl acetoacetate (2), 4-chlorobenzaldehyde (3a), urea (4) under different conditions in the presence of MCM-41-APS-PMDA-NHSO3H (1).a
| Entry | Catalyst loading (mg) | Solvent | Temperature (°C) | Time (min) | Yieldb (%) |
|---|---|---|---|---|---|
| 1 | 20 | MeOH | r.t | 180 | 26 |
| 2 | 20 | EtOH | Reflux | 90 | 69 |
| 3 | 20 | CH2Cl2 | Reflux | 90 | 45 |
| 4 | 20 | CH3CN | 60 | 120 | 78 |
| 5 | 20 | DMF | Reflux | 100 | 62 |
| 6 | 20 | Toluene | Reflux | 150 | 48 |
| 7 | 20 | Et2O | r.t | 240 | 35 |
| 8 | 20 | CHCl3 | 60 | 120 | 75 |
| 9 | 20 | EtOH/H2O (1:2) | Reflux | 55 | 77 |
| 10 | 20 | EtOH/H2O (1:1) | Reflux | 70 | 73 |
| 11 | 15 | Solvent-free | 80 | 35 | 95 |
| 12 | 10 | Solvent-free | 80 | 65 | 69 |
| 13 | 5 | Solvent-free | 80 | 90 | 60 |
| 14 | 2 | Solvent-free | 80 | 120 | 57 |
| 15 | 0 | Solvent-free | 80 | 180 | 15 |
aReaction conditions: ethyl acetoacetate (2, 1 mmol), 4-chlorobenzaldehyde (3a, 1 mmol), urea (4, 1.2 mmol), MCM-41-APS-PMDA-NHSO3H (1) and solvent (2 ml, if not otherwise stated).
Scope of the Biginelli condensation for the synthesis of 3,4-dihydropyrimidin-2-(1H)-ones catalyzed by MCM-41-APS-PMDA-NHSO3H (1)a.
| Entry | Aldehyde 3 | Product 5 | Time (min) | Yield (%)b | mp °C (Obs.) | mp °C (Lit.) |
|---|---|---|---|---|---|---|
| 1 | 4-ClC6H4– |
| 35 | 95 | 210–211 | 210–211[ |
| 2 | C6H5– |
| 55 | 87 | 235–236 | 234–236[ |
| 3 | 4-NO2C6H4– |
| 50 | 80 | 204 | 224–227[ |
| 4 | 3-NO2C6H4– |
| 60 | 82 | 293–295 | 204[ |
| 5 | 4-CH3OC6H4– |
| 55 | 89 | 201–203 | 202–204[ |
| 6 | 2-ClC6H4– |
| 60 | 90 | 211–213 | 211–213[ |
| 7 | 4-OHC6H4– |
| 55 | 82 | 234–236 | 233–235[ |
| 8 | 2-C4H3S– |
| 45 | 84 | 212–214 | 210–212[ |
| 9 | 4-Me2NC6H4– |
| 45 | 92 | 213–215 | 213–215[ |
| 10 | 4-FC6H4– |
| 60 | 85 | 180 | 180[ |
| 11 | 4-OH-3-MeO-C6H3– |
| 40 | 84 | 188–190 | 188.5[ |
aReaction conditions: ethyl acetoacetate (2, 1 mmol), aldehydes (3a–k, 1 mmol), urea (4, 1.2 mmol), MCM-41-APS-PMDA-NHSO3H (1, 15 mg) under solvent-free conditions at 80 °C.
bIsolated yields were reported.
Scheme 2Proposed mechanism for the synthesis of 3,4-dihydropyrimidin-2(1H)-ones catalyzed by MCM-41 (MCM-41-APS-PMDA-NHSO3H (1).
Figure 7Reusability of the heterogeneous acidic nanocatalyst MCM-41-APS-PMDA-NHSO3H (1) for the synthesis of 5a.
Comparison of the catalytic activity of the MCM-41-APS-PMDA-NHSO3H (1) with other catalysts.
| Entry | Catalyst | Amount of catalyst loading | Solvent | Temp. (°C) | Time (min) | Yield (%) | References |
|---|---|---|---|---|---|---|---|
| 1 | PPF-SO3H | 250 mg | EtOH | Reflux | 480 | 81 | [ |
| 2 | PANI-FeCl3 | 200 mg | CH3CN | Reflux | 1440 | 83 | [ |
| 3 | Fe3O4/PAA-SO3H | 60 mg | Solvent-free | RT | 120 | 90 | [ |
| 4 | H2SO4.Silica gel | 30 mol ⁒(47 mg) | Solvent-free | 60 °C | 120 | 89 | [ |
| 5 | Zr(H2PO4)2 | 7 mol ⁒(20 mg) | Solvent-free | 90 °C | 60 | 92 | [ |
| 6 |